• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. News
  3. First DNA Passports have arrived!
News | 26/11/2024
PSY-PGX CLINICAL STUDY

First DNA Passports have arrived!

Feedback on Metabolizer Status
We have received the first copies of the PSY-PGx DNA Passports! These documents give information on the genetically-inferred Metabolizer Status for many psychiatric medications. Participants of the PSY-PGx Clinical Study can obtain these at the end of the study, if wanted.
PSY-PGx DNA Passport
Ross van Westrhenen

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
p qguéicbDpWziuiuSöcјæsnuä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety